FILTER
FILTERED INTERVIEW RESULTS
Gil Roth
PRESIDENT, PBOA
"The Ukraine crisis highlighted how Europe needs to look at its energy supply and how it will make sure they have secure supply chains. Part of that has involved the US more closely. Geopolitics will have a more significant impact going forward."
Terry Myerson
CEO, TRUVETA
"Truveta Studio is the first data and analytics solution to study patient care and outcomes for all conditions, drugs, and medical devices. Pfizer is using Truveta Studio to study COVID-19."
Liping Liu
FOUNDER & CEO, HIGHTIDE THERAPEUTICS
"As more robust drug candidates are emerging, I am willing to bet that we will have the first NASH drug approved in 2023."
Scott Bedell
PRESIDENT, CALTROL INC.
"Companies are asking for more return from past automation investments and additional, relevant data for decision-making."
Ravi Sahu
CEO, STRAYOS
"They know AI is one of the tools that can help them realize their goals. So Arizona and Nevada are strategic markets for us."
John Seaberg
CEO, NV GOLD CORP.
"The next multi-million-ounce discovery in Nevada will be undercover, and we are in an advantageous position as our land package is second to none regarding other juniors in Nevada."
Andrew Caruso
PRESIDENT & CEO, NEW MOLY LLC
"There are only two primary molybdenum mines outside of China today: Freeport McMorran’s Climax and Henderson mines, so Mt. Hope would offer the world a new source of the metal not controlled by China.
Tyre Gray
PRESIDENT AND CEO, NEVADA MINING ASSOCIATION
"We have a unique understanding of how to mine in a more innovative, sustainable, and safe way."
Ronald Thiessen
CEO, NORTHERN DYNASTY MINERALS LTD.
"Pebble is a critical asset: it is the largest undeveloped copper project in the world, and it is polymetallic."
Mark Bristow
PRESIDENT & CEO, BARRICK GOLD
"Our successful exploration programs are feeding high-quality prospects into an already bulging pipeline and we expect to grow our reserves net of depletion again this year."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
